Braca is the lead author of a new study recently presented at the European Academy of Neurology (EAN) Congress 2025 that has found that glucagon-like peptide-1 (GLP-1) receptor agonist medications used to treat type 2 diabetes and obesity may help cut a persons monthly migraine days by about half
Of note it is also FDA approved for treatment of obstructive sleep apnea
Early research suggests patches might lower some gastrointestinal side effects by releasing medication more steadily, but this has not been confirmed in human studies
Affirm may perform a hard check for larger financing amounts, but they disclose this clearly before you proceed
Across published clinical trial work, researchers have studied it for weight management, weight reduction, body composition, fat loss, appetite suppression, and broader metabolic regulation, with reported doses up to 12mg by subcutaneous injection
Behavioral and Lifestyle Habits: Developing healthy habits around sleep, stress management, and hydration can amplify tirzepatides effectiveness